To investigate whether FABP4 inhibitor provides a renoprotective effect on septic AKI, the mice were orally administered BMS309403 at a dose of 40 mg/kg/d for 3 days before CLP or LPS injection. The gene discussed is FABP4; the disease is acute kidney injury.